drugset / Trial / NCT06819774

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

NCT06819774

Phase 3 Recruiting 284 enrolled Shandong New Time Pharmaceutical Co., LTD
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.

Timeline

Start
2024-04-22
Primary completion
2025-08
Completion
2025-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 1 ml Intravenous
Subject Cetirizine Other / unclassified 2 ml Intravenous
Subject Diphenhydramine Unknown 1 ml Intramuscular

Indications